INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 434m ago
HOUSE PTR34m ago
SEC 13F34m ago
ROBINHOOD CHAIN34m ago
SEC FORM 4/Option exerciseVerified data

Budur Kumar reported HRMY

CHIEF MEDICAL OFFICER · Harmony Biosciences Holdings, Inc. · Common Stock

Side
M
Value
$12K
Shares
400
Price
$30.27
Executed
Sep 17, 2026
Disclosed
Sep 18, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 17 executedSep 18, 2026 disclosed

HRMY · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
5/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+1 / 25

$12K reported value · 3.0% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+4 / 15

    5 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · HRMY

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    20
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$319K
    10.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    20
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$770K
    25.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    21
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$34K
    800 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    24
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$77K
    1,800 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$27K
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    14
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    25.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    14
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    10.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    35
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$1.54M
    35.9K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    9
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$28K
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$12K
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    23
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$374K
    12.2K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    19
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$326K
    10.8K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    17
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    12.2K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    13
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    10.8K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    35
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$989K
    23.0K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    21
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$43K
    1,000 sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002009762-26-000006
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Sep 17, 2026
    Published
    Sep 18, 2026
    Ingested by INSIDER
    Nov 5, 02:16 UTC
    Last re-read
    Nov 5, 02:16 UTC

    Extracted facts

    Filer
    Budur Kumar
    Role
    CHIEF MEDICAL OFFICER
    Transaction
    Option exerciseAs filed: “M”
    Asset
    Harmony Biosciences Holdings, Inc.
    Ticker
    HRMY
    Shares
    400
    Price per share
    $30.27
    Value
    $12,108
    Execution date (reported)
    Sep 17, 2026
    Owned after transaction
    13.9K shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 400
    • Price: $30.27

    = $12,108

    What this establishes

    Budur Kumar filed this Form 4 reporting a option exercise of HRMY on Sep 17, 2026. It became public on Sep 18, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    CHIEF MEDICAL OFFICER
    Budur Kumarcik:0002009762
    Issuer
    Harmony Biosciences Holdings, Inc.cik:0001802665

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.